Showing latest transactions and SEC Form 4 filings for MIRM.
18 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-11-17 17:00:49 | 2026-11-16 | MIRM | Mirum Pharmaceuticals, Inc. | Ramasastry Saira | Director | M - OptEx | $14.49 | +4,000 | 2,000 | 0% | +$57,940 |
| D | 2026-11-17 17:00:49 | 2026-11-16 | MIRM | Mirum Pharmaceuticals, Inc. | Ramasastry Saira | Director | S - Sale+OE | $92.28 | -2,000 | 2,000 | -50% | -$184,560 |
| D | 2026-11-13 16:54:50 | 2026-11-11 | MIRM | Mirum Pharmaceuticals, Inc. | Brege Laura | Director | M - OptEx | $8.36 | +28,334 | 64,536 | 0% | +$236,731 |
| D | 2026-11-13 16:54:50 | 2026-11-11 | MIRM | Mirum Pharmaceuticals, Inc. | Brege Laura | Director | S - Sale+OE | $94.21 | -14,167 | 64,536 | -5% | -$1,334,656 |
| D | 2026-11-04 20:46:04 | 2026-11-04 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CHIEF EXECUTIVE OFFICER, Director | M - OptEx | $1.47 | +40,000 | 620,774 | 0% | +$58,720 |
| D | 2026-11-04 20:46:04 | 2026-11-04 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CHIEF EXECUTIVE OFFICER, Director | S - Sale+OE | $90.00 | -20,000 | 620,774 | -3% | -$1,800,000 |
| D | 2026-10-19 16:10:05 | 2026-10-16 | MIRM | Mirum Pharmaceuticals, Inc. | Howe Jolanda | SVP, GLOBAL CONTROLLER | M - OptEx | $9.62 | +32,224 | 16,728 | 0% | +$309,995 |
| D | 2026-10-14 16:06:52 | 2026-10-09 | MIRM | Mirum Pharmaceuticals, Inc. | Myers Robert Paul | Chief Medical Officer | A | $0.00 | +65,000 | 0 | 0% | $0 |
| D | 2026-10-06 20:38:23 | 2026-10-06 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | CHIEF EXECUTIVE OFFICER, Director | M - OptEx | $8.66 | +24,394 | 593,882 | 0% | +$211,179 |